Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.72 USD -0.8% Market Closed
Market Cap: 40.1m USD

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Lowest
Price Target
18.18 USD
389% Upside
Average
Price Target
22.44 USD
503% Upside
Highest
Price Target
27.3 USD
634% Upside
Lantern Pharma Inc. Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
42% Upside
298380
ABL Bio Inc
39% Upside
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
PRQR
ProQR Therapeutics NV
494% Upside
MAB
Mabion SA
20% Downside
BSLN
Basilea Pharmaceutica AG
75% Upside
CUV
Clinuvel Pharmaceuticals Ltd
123% Upside
KRRO
Korro Bio Inc
537% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Back to Top